NDC 71205-200

Lorazepam

Lorazepam

Lorazepam is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Proficient Rx Lp. The primary component is Lorazepam.

Product ID71205-200_ce8827b1-18ff-4f23-adfb-8ddcc15a6a81
NDC71205-200
Product TypeHuman Prescription Drug
Proprietary NameLorazepam
Generic NameLorazepam
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2007-01-08
Marketing End Date2021-09-30
Marketing CategoryANDA / ANDA
Application NumberANDA071141
Labeler NameProficient Rx LP
Substance NameLORAZEPAM
Active Ingredient Strength2 mg/1
Pharm ClassesBenzodiazepine [EPC],Benzodiazepines [CS]
DEA ScheduleCIV
NDC Exclude FlagN

Packaging

NDC 71205-200-20

20 TABLET in 1 BOTTLE (71205-200-20)
Marketing Start Date2019-01-01
Marketing End Date2021-09-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71205-200-10 [71205020010]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA071141
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-01-01
Marketing End Date2019-09-30

NDC 71205-200-05 [71205020005]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA071141
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-01-01
Marketing End Date2019-09-30

NDC 71205-200-90 [71205020090]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA071141
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-01-01
Marketing End Date2021-09-30

NDC 71205-200-20 [71205020020]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA071141
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-01-01
Marketing End Date2021-09-30

NDC 71205-200-60 [71205020060]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA071141
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-01-01
Marketing End Date2021-09-30

NDC 71205-200-30 [71205020030]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA071141
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-01-01
Marketing End Date2021-09-30

Drug Details

Active Ingredients

IngredientStrength
LORAZEPAM2 mg/1

OpenFDA Data

SPL SET ID:d2887ee1-bfd4-41f6-9fd3-6496cc78c744
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197902

    • Pharmacological Class

    • Benzodiazepine [EPC]
    • Benzodiazepines [CS]

    NDC Crossover Matching brand name "Lorazepam" or generic name "Lorazepam"

    NDCBrand NameGeneric Name
    0054-3532LorazepamLorazepam
    0093-3425LorazepamLorazepam
    0093-3426LorazepamLorazepam
    0093-3427LorazepamLorazepam
    0121-0770LorazepamLorazepam
    67544-982LorazepamLorazepam
    0409-6779LorazepamLorazepam
    0409-6778LorazepamLorazepam
    0409-6780LorazepamLorazepam
    68071-3010LorazepamLorazepam
    68071-3227LorazepamLorazepam
    68071-3121LorazepamLorazepam
    68071-3242LorazepamLorazepam
    68071-3096LorazepamLorazepam
    68084-736LorazepamLorazepam
    68084-742LorazepamLorazepam
    68084-754LorazepamLorazepam
    68788-0241LorazepamLorazepam
    68788-9511LorazepamLorazepam
    68788-7355LorazepamLorazepam
    68788-7411LorazepamLorazepam
    68788-9839LorazepamLorazepam
    68788-9258LorazepamLorazepam
    68788-9840LorazepamLorazepam
    68788-9982LorazepamLorazepam
    69315-904LorazepamLorazepam
    69315-906LorazepamLorazepam
    69315-905LorazepamLorazepam
    0591-0240LorazepamLorazepam
    0591-0241LorazepamLorazepam
    0591-0242LorazepamLorazepam
    70518-0155LorazepamLorazepam
    70518-0486LorazepamLorazepam
    70518-0275LorazepamLorazepam
    70518-0156LorazepamLorazepam
    70518-0445LorazepamLorazepam
    70518-1045LorazepamLorazepam
    70518-1431LorazepamLorazepam
    70518-1520LorazepamLorazepam
    70518-1313LorazepamLorazepam
    70518-1679LorazepamLorazepam
    70518-1255LorazepamLorazepam
    0603-4246LorazepamLorazepam
    71205-200LorazepamLorazepam
    71205-235LorazepamLorazepam
    71205-228LorazepamLorazepam
    71205-166LorazepamLorazepam
    71335-0277LorazepamLorazepam
    71335-0655LorazepamLorazepam
    71335-0204LorazepamLorazepam
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.